Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-005006-66Phase 4Completed
Phase 4, randomised, single-blind trial of Camphor in nasal congestion and nasopharyngitis (2 arms), sponsored by Procter & Gamble. Primary endpoint: Time to first experiencing sensation of nasal cooling. Started Dec 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-005006-66.